- Yahoo Finance
Alzheimer's drug Leqembi: The twice-monthly infusion could be available in injection form
An Alzheimer's drug in injectable form could be the key for Biogen, Eisai to ease pressures and concerns of a limited market and revenue.
- Yahoo Finance
New Alzheimer's drug success 'was built on failures': Eisai exec
Eisai just reached the finish line with its long-fought battle to gain Medicare approval for Alzheimer's drug Leqembi. But the company says more work remains.
- Yahoo Finance
New Alzheimer's drug from Biogen, Eisai gets government approval, but faces long road ahead
Biogen and Eisai's second attempt at a new class of Alzheimer's treatments faces pressure despite regulatory and CMS greenlight.
